Binary CaO-SiO(2) gel-glasses for biomedical applications.

Bioactive materials are routinely used in dental and orthopaedic applications. The concept was first introduced in 1971, with the discovery of 45S5 Bioglass, which is known to develop an interfacial bond between the implant and the host tissue. This glass is composed of SiO(2), CaO, P(2)O(5) and Na(2)O. Since then numerous glasses and glass ceramics with similar compositions have been extensively studied for clinical applications. Until 1990 it was accepted that P(2)O(5) and Na(2)O were necessary components for the glass composition to be bioactive. However, calcium silicate glasses with high SiO(2) content are impossible to produce using the traditional melt-quench method. This is due to the liquid-liquid immiscibility region that is present between 0.02 and 0.3 mole fraction of CaO and in terms of bioactivity, high CaO compositions were inferior to those quaternary bioactive glass compositions already in existence. In the last few years several studies have been reported regarding the production of CaO-SiO(2) glasses via the sol-gel processing technique. This report summarises the findings of the past and the present and also outlines potential of these calcium silicate gel-glasses in the field of biomaterials.

[1]  L. Hench,et al.  In vitro release kinetics of proteins from bioactive foams. , 2003, Journal of biomedical materials research. Part A.

[2]  L. Hench,et al.  Mesoporous calcium silicate glasses. I. Synthesis , 2003 .

[3]  L. Hench,et al.  Mesoporous calcium silicate glasses. II. Textural characterisation , 2003 .

[4]  Y. Schneider,et al.  Indirect cytotoxicity evaluation of pseudowollastonite , 2003, Journal of materials science. Materials in medicine.

[5]  L. Hench,et al.  Effect of Particle Size on the Concentration and Rate of Ag+ Release from Antimicrobial SiO2-CaO-P2O5-Ag2O Gel-Glasses , 2002 .

[6]  L. Hench,et al.  Effect of Composition and Texture on Controlled Rate Release of an Antibacterial Agent from Bioactive Gel-Glasses , 2002 .

[7]  L. Hench,et al.  Characterisation of a Novel Nitric Oxide Releasing Bioactive Glass , 2002 .

[8]  L. Hench,et al.  Surface-modified 3D scaffolds for tissue engineering , 2002, Journal of materials science. Materials in medicine.

[9]  Larry L. Hench,et al.  Broad-Spectrum Bactericidal Activity of Ag2O-Doped Bioactive Glass , 2002, Antimicrobial Agents and Chemotherapy.

[10]  Julian R Jones,et al.  Bioactive sol-gel foams for tissue repair. , 2002, Journal of biomedical materials research.

[11]  J. Polak,et al.  Study of Osteoblast Differentiation and Proliferation on the Surface of Binary Bioactive Gel-Glasses , 2001 .

[12]  J. Schierholz,et al.  Implant infections: a haven for opportunistic bacteria. , 2001, The Journal of hospital infection.

[13]  L L Hench,et al.  Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. , 2001, Journal of biomedical materials research.

[14]  L. Hench,et al.  Low-temperature synthesis, structure, and bioactivity of gel-derived glasses in the binary CaO-SiO2 system. , 2001, Journal of biomedical materials research.

[15]  Lorna J. Gibson,et al.  Cellular materials as porous scaffolds for tissue engineering , 2001 .

[16]  J. Polak,et al.  Bioactive materials to control cell cycle , 2000 .

[17]  J. Polak,et al.  Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. , 2000, Biochemical and biophysical research communications.

[18]  M. Vallet‐Regí,et al.  Bioactivity of a CaO−SiO2 Binary Glasses System , 2000 .

[19]  L. Hench,et al.  Bacteriostatic action of a novel four-component bioactive glass. , 2000, Journal of biomedical materials research.

[20]  L. Hench.  A Genetic Theory of Bioactive Materials , 2000 .

[21]  R. Oréfice,et al.  Sol-gel silica based networks with controlled chemical properties , 2000 .

[22]  D J Mooney,et al.  Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[23]  B. Roos,et al.  Influence of laminin substratum on cell proliferation and CALC I gene expression in medullary thyroid carcinoma C cell lines , 1999, Molecular and Cellular Endocrinology.

[24]  J. Binner,et al.  Processing of cellular ceramics by foaming and in situ polymerisation of organic monomers , 1999 .

[25]  K. Healy.  Molecular engineering of materials for bioreactivity , 1999 .

[26]  B. Ratner,et al.  Recognition Templates for Biomaterials with Engineered Bioreactivity , 1999 .

[27]  J. Lu,et al.  Role of interconnections in porous bioceramics on bone recolonization in vitro and in vivo , 1999, Journal of materials science. Materials in medicine.

[28]  M. Catauro,et al.  Low temperature synthesis, structure and bioactivity of xCaO· (1−x)SiO2 glasses , 1997 .

[29]  X. F. Chen,et al.  The evaluation of degradability of melt and sol-gel derived bioglass® in-vitro , 1997 .

[30]  S. Radin,et al.  In vitro release kinetics of biologically active transforming growth factor-β1 from a novel porous glass carrier , 1997 .

[31]  L. Hench,et al.  Mechanisms of hydroxyapatite formation on porous gel-silica substrates , 1996 .

[32]  Larry L. Hench,et al.  Bioceramics: Materials and Applications II , 1996 .

[33]  A. Clark,et al.  Calcium phosphate formation on sol-gel-derived bioactive glasses in vitro. , 1994, Journal of biomedical materials research.

[34]  C. Sanchez,et al.  Sol-gel chemistry , 1992 .

[35]  Larry L. Hench,et al.  Bioceramics: From Concept to Clinic , 1991 .

[36]  D. Scudiero,et al.  Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. , 1991, Cancer research.

[37]  T. Yamamuro,et al.  Bone-bonding ability of P2O5-free CaO.SiO2 glasses. , 1991, Journal of biomedical materials research.

[38]  T. Yamamuro,et al.  Bioactivity of CaO·SiO2-based glasses:in vitro evaluation , 1990 .

[39]  N. Bansal.  Influence of Several Metal lons on the Gelation Activation Energy of Silicon Tetraethoxide , 1990 .

[40]  L. Hench,et al.  The sol-gel process , 1990 .

[41]  T. Yamamuro,et al.  Bonding behavior of a glass-ceramic containing apatite and wollastonite in segmental replacement of the rabbit tibia under load-bearing conditions. , 1989, The Journal of bone and joint surgery. American volume.

[42]  T. Yamamuro,et al.  Strength of bonding between A-W glass-ceramic and the surface of bone cortex. , 1988, Journal of biomedical materials research.

[43]  T. Kokubu,et al.  SEM-EPMA observation of three types of apatite-containing glass-ceramics implanted in bone: the variance of a Ca-P-rich layer. , 1987, Journal of biomedical materials research.

[44]  G. Ito,et al.  A histological comparison of the tissue interface of bioglass and silica glass. , 1987, Journal of biomedical materials research.

[45]  Sumio Sakka,et al.  Formation of a high-strength bioactive glass-ceramic in the system MgO-CaO-SiO2-P2O5 , 1986 .

[46]  T. Yamamuro,et al.  A new glass-ceramic for bone replacement: evaluation of its bonding to bone tissue. , 1985, Journal of biomedical materials research.

[47]  H. Saito,et al.  Preparation of CaO-SiO2 glasses by the gel method , 1980 .

[48]  L L Hench,et al.  Direct chemical bond of bioactive glass-ceramic materials to bone and muscle. , 1973, Journal of biomedical materials research.

[49]  Larry L. Hench,et al.  Bonding mechanisms at the interface of ceramic prosthetic materials , 1971 .